Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Condition(s):Oropharyngeal NeoplasmsLast Updated:October 26, 2006Unknown status
Hide Studies Not Open or Pending
Condition(s):Oropharyngeal NeoplasmsLast Updated:October 26, 2006Unknown status
Condition(s):Breast Cancer; Radiation ToxicityLast Updated:March 21, 2018Completed
Condition(s):Breast Cancer; Radiation ToxicityLast Updated:March 12, 2018Completed
Condition(s):Breast CancerLast Updated:September 14, 2023Recruiting
Condition(s):Radiotherapy Side EffectLast Updated:September 11, 2020Unknown status
Condition(s):Breast CancerLast Updated:August 1, 2023Recruiting
Condition(s):Limited Disease Small Cell Lung CancerLast Updated:October 19, 2012Unknown status
Condition(s):Head and Neck CancerLast Updated:January 24, 2014Completed
Condition(s):Head and Neck CancerLast Updated:June 14, 2022Completed
Condition(s):Nasopharyngeal CarcinomaLast Updated:August 21, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.